Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
International Journal of Cancer
|
June 25, 1998
Anti-prostate immunotoxins: cytotoxicity of E4 antibody-Pseudomonas exotoxin constructs
M Essand, I Pastan
Journal of Internal Medicine
|
December 4, 2012
Genetically engineered T cells for the treatment of cancer
M Essand, A S I Loskog
Anticancer Research
|
September 1, 1993
Growth of prostatic cancer cells, DU 145, as multicellular spheroids and effects of estramustine
M Essand, S Nilsson, J Carlsson
Cancer Gene Therapy
|
October 21, 2006
Two-step amplification of the human PPT sequence provides specific gene expression in an immunocompetent murine prostate cancer model
H Dzojic, W-S Cheng, M Essand
Cancer Gene Therapy
|
January 12, 2008
Increased therapeutic efficacy of the prostate-specific oncolytic adenovirus Ad[I/PPT-E1A] by reduction of the insulator size and introduction of the full-length E3 region
A Danielsson, H Dzojic, B Nilsson, et al.
International Journal of Cancer
|
November 3, 1995
Radioimmunotherapy of prostatic adenocarcinomas: effects of 131I-labelled E4 antibodies on cells at different depth in DU 145 spheroids
M Essand, C Grönvik, T Hartman, et al.
The Prostate
|
January 1, 1992
Radiation sensitization by estramustine studies on cultured human prostatic cancer cells
S Eklöv, M Essand, J Carlsson, et al.
Cancer Research
|
November 24, 2001
T-cell receptor gamma chain alternate reading frame protein (TARP) expression in prostate cancer cells leads to an increased growth rate and induction of caveolins and amphiregulin
C D Wolfgang, M Essand, B Lee, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
June 1, 2011
Oncolytic viruses for the treatment of neuroendocrine tumors
M Essand, J Leja, V Giandomenico, et al.
International Journal of Oncology
|
May 12, 2011
The monoclonal anti-cytokeratin-8 antibody, 6d7, targets quiescent cells in prostatic-carcinoma spheroids
M Essand, C Lindholm, A Silen, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
International Journal of Cancer
|
June 25, 1998
Anti-prostate immunotoxins: cytotoxicity of E4 antibody-Pseudomonas exotoxin constructs
M Essand, I Pastan
Journal of Internal Medicine
|
December 4, 2012
Genetically engineered T cells for the treatment of cancer
M Essand, A S I Loskog
Anticancer Research
|
September 1, 1993
Growth of prostatic cancer cells, DU 145, as multicellular spheroids and effects of estramustine
M Essand, S Nilsson, J Carlsson
Cancer Gene Therapy
|
October 21, 2006
Two-step amplification of the human PPT sequence provides specific gene expression in an immunocompetent murine prostate cancer model
H Dzojic, W-S Cheng, M Essand
Cancer Gene Therapy
|
January 12, 2008
Increased therapeutic efficacy of the prostate-specific oncolytic adenovirus Ad[I/PPT-E1A] by reduction of the insulator size and introduction of the full-length E3 region
A Danielsson, H Dzojic, B Nilsson, et al.
International Journal of Cancer
|
November 3, 1995
Radioimmunotherapy of prostatic adenocarcinomas: effects of 131I-labelled E4 antibodies on cells at different depth in DU 145 spheroids
M Essand, C Grönvik, T Hartman, et al.
The Prostate
|
January 1, 1992
Radiation sensitization by estramustine studies on cultured human prostatic cancer cells
S Eklöv, M Essand, J Carlsson, et al.
Cancer Research
|
November 24, 2001
T-cell receptor gamma chain alternate reading frame protein (TARP) expression in prostate cancer cells leads to an increased growth rate and induction of caveolins and amphiregulin
C D Wolfgang, M Essand, B Lee, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
June 1, 2011
Oncolytic viruses for the treatment of neuroendocrine tumors
M Essand, J Leja, V Giandomenico, et al.
International Journal of Oncology
|
May 12, 2011
The monoclonal anti-cytokeratin-8 antibody, 6d7, targets quiescent cells in prostatic-carcinoma spheroids
M Essand, C Lindholm, A Silen, et al.
Page
of 3